Blog Category: Preprints

As part of Clinician’s Corner we would like practicing clinicians to share their opinions and experiences on preprint usage within the clinical community. In this post, we speak to Dr Karin Purshouse, an ECAT Clinical Lecturer in Medical Oncology and PhD Fellow at the University of Edinburgh.

This week marks Open Access Week 2020, which is running with the theme “Open with Purpose: Taking Action to Build Structural Equity and Inclusion.” The theme provides a reminder that openness in science communication is a means to other uses rath... The same principle applies to preprints; we want to build on the benefits of faster communication that preprints bring to ultimately allow science to progress faster and researchers to receive credit for their work earlier.

Community feedback on preprints makes rapid science more robust. Review and commentary can help authors improve their articles; curation can provide readers with helpful context and enhance discoverability.

A series aimed at opening the dialogue surrounding preprint usage in the clinical community. Run by the ASAPbio Fellows Vanessa Bortoluzzi, Kirsty Ferguson, Suraj Kannan and Aleksandra Petelski.

In late 2019, EMBO and ASAPbio launched Review Commons, a platform for journal-independent peer review that facilitates the posting of a refereed preprint and submission to 17 partner journals. With this system, we aimed to improve peer review in three ways: Review Commons is an experiment, and as such, we’re committed to measuring and evaluating the outcomes of the project.

Scientific manuscripts often spend months, sometimes years, in the hands of a restricted number of reviewers and editors before they are ultimately released to the rest of the scientific community after peer review. In recent years, the growing usage of preprints in the life sciences has revolutionized the publishing system by allowing the separation of the communication of scientific discoveries from their assessment by scientists, editors and journals.